Literature DB >> 23157991

A neuropsychiatric perspective of phenylketonuria I: overview of phenylketonuria and its neuropsychiatric sequelae.

Ashley Bone1, Angela K Kuehl, Andrew F Angelino.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatment of PKU are presented. Neurocognitive and neuropsychiatric sequelae of patients with untreated, early-treated, and continuously-treated PKU are described, and possible mechanisms for the symptoms are proposed. The authors propose an integrated approach to management of patients with PKU.
Copyright © 2012 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157991     DOI: 10.1016/j.psym.2012.04.010

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  4 in total

1.  Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.

Authors:  Charlotte Veyrat-Durebex; Christelle Debeissat; Hélène Blasco; Franck Patin; Hélène Henique; Patrick Emond; Catherine Antar; Valérie Gissot; Olivier Herault; François Maillot
Journal:  JIMD Rep       Date:  2017-03-15

2.  Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.

Authors:  T Mlčoch; R Puda; P Ješina; M Lhotáková; Š Štěrbová; T Doležal
Journal:  Eur J Clin Nutr       Date:  2017-06-28       Impact factor: 4.016

3.  The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase.

Authors:  Oscar Aubi; Karina S Prestegård; Kunwar Jung-Kc; Tie-Jun Sten Shi; Ming Ying; Ann Kari Grindheim; Tanja Scherer; Arve Ulvik; Adrian McCann; Endy Spriet; Beat Thöny; Aurora Martinez
Journal:  Nat Commun       Date:  2021-04-06       Impact factor: 14.919

4.  A benefit-risk analysis of pegvaliase for the treatment of phenylketonuria: A study of patients' preferences.

Authors:  Sumitra SriBhashyam; Kevin Marsh; Adrian Quartel; Haoling H Weng; Ari Gershman; Nicola Longo; Janet Thomas; Roberto Zori
Journal:  Mol Genet Metab Rep       Date:  2019-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.